Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FR9RR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $118,981
Award facts
- Contract value 100% obligated
- $118,980.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $118,980.64 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose auto-injector pens on August 15, 2025, with completion scheduled for August 18, 2025. This firm fixed-price, non-set-aside contract represents a pediatric pharmaceutical delivery supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its extensive federal contract portfolio with the Defense Logistics Agency.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract award demonstrates the vendor's capability to meet competitive federal procurement requirements and reflects the DLA's strategy for maintaining robust pharmaceutical supply chains across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FR9RR?
SPE2DB25FR9RR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FR9RR worth?
The government has obligated $118,981 on SPE2DB25FR9RR.
Is contract SPE2DB25FR9RR an order under another contract?
Yes. SPE2DB25FR9RR is a delivery order under SPE2DB22D2103, an indefinite delivery contract.
Was contract SPE2DB25FR9RR competed?
The extent of competition for SPE2DB25FR9RR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award